These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 27884951)

  • 21. [Flexible intensive insulin therapy: a change in mentalities].
    Penfornis A; Chabroux S; Grimaldi A
    Rev Med Interne; 2008 Nov; 29(11):857-60. PubMed ID: 18387717
    [No Abstract]   [Full Text] [Related]  

  • 22. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical Activity Capture Technology With Potential for Incorporation Into Closed-Loop Control for Type 1 Diabetes.
    Dadlani V; Levine JA; McCrady-Spitzer SK; Dassau E; Kudva YC
    J Diabetes Sci Technol; 2015 Oct; 9(6):1208-16. PubMed ID: 26481641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatrics, Pens, and Pumps.
    Hieronymus L; Hepner A; Cherolis J
    Diabetes Self Manag; 2015; 32(2):20-3. PubMed ID: 26665831
    [No Abstract]   [Full Text] [Related]  

  • 25. To mix or to separate: that is the question.
    Cho YM
    Lancet Diabetes Endocrinol; 2015 Apr; 3(4):229-31. PubMed ID: 25754416
    [No Abstract]   [Full Text] [Related]  

  • 26. Cromolyn sodium for insulin-induced lipoatrophy: old drug, new use.
    Phua EJ; Lopez X; Ramus J; Goldfine AB
    Diabetes Care; 2013 Dec; 36(12):e204-5. PubMed ID: 24265375
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacologic treatment options for type 1 diabetes: what's new?
    Nally LM; Sherr JL; Van Name MA; Patel AD; Tamborlane WV
    Expert Rev Clin Pharmacol; 2019 May; 12(5):471-479. PubMed ID: 30892094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electroconvulsive therapy and monoamine oxidase inhibitors.
    Ribeiro RB; Rosa MA; Rigonatti SP
    Braz J Psychiatry; 2008 Dec; 30(4):406-7. PubMed ID: 19142425
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined phenylephrine and tranylcypromine for postural hypotension.
    Itskovitz HD; Wartenburg A
    Am Heart J; 1983 Sep; 106(3):598-9. PubMed ID: 6881039
    [No Abstract]   [Full Text] [Related]  

  • 30. Will Biosimilar Insulins Be Cheaper?
    Heinemann L; Carter AW
    Diabetes Technol Ther; 2017 Sep; 19(9):513-515. PubMed ID: 28885037
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypoglycemic action of monoamineoxidase inhibitors (MAOI'S).
    Adnitt PI
    Diabetes; 1968 Oct; 17(10):628-33. PubMed ID: 5681080
    [No Abstract]   [Full Text] [Related]  

  • 32. Paradoxical Hyperplasia After Cryolipolysis in 2 Patients With Diabetes on Insulin Pumps.
    Moustafa F; Christman M; Zachary C; Kaminer MS
    Dermatol Surg; 2021 Jun; 47(6):868-869. PubMed ID: 33021509
    [No Abstract]   [Full Text] [Related]  

  • 33. Electroencephalographic studies in diabetes mellitus.
    GREENBLATT M; MURRAY J; ROOT HF
    N Engl J Med; 1946 Jan; 234():119-21. PubMed ID: 21011363
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased DNA methylation variability in type 1 diabetes across three immune effector cell types.
    Paul DS; Teschendorff AE; Dang MA; Lowe R; Hawa MI; Ecker S; Beyan H; Cunningham S; Fouts AR; Ramelius A; Burden F; Farrow S; Rowlston S; Rehnstrom K; Frontini M; Downes K; Busche S; Cheung WA; Ge B; Simon MM; Bujold D; Kwan T; Bourque G; Datta A; Lowy E; Clarke L; Flicek P; Libertini E; Heath S; Gut M; Gut IG; Ouwehand WH; Pastinen T; Soranzo N; Hofer SE; Karges B; Meissner T; Boehm BO; Cilio C; Elding Larsson H; Lernmark Å; Steck AK; Rakyan VK; Beck S; Leslie RD
    Nat Commun; 2016 Nov; 7():13555. PubMed ID: 27898055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Mitochondria in Metabolic Syndrome-Associated Cardiomyopathy.
    Li J; Li J; Chen Y; Hu W; Gong X; Qiu H; Chen H; Xin Y; Li H
    Oxid Med Cell Longev; 2022; 2022():9196232. PubMed ID: 35783195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy.
    Kaludercic N; Di Lisa F
    Front Cardiovasc Med; 2020; 7():12. PubMed ID: 32133373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycaemic control by monoamine oxidase inhibition in a patient with type 1 diabetes.
    Emory H; Mizrahi N
    Diab Vasc Dis Res; 2017 Mar; 14(2):163-165. PubMed ID: 27884951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two Subsequent Pregnancies in a Woman With Type 1 Diabetes: Artificial Pancreas Was a Gamechanger.
    Schütz-Fuhrmann I; Schütz AK; Eichner M; Mader JK
    J Diabetes Sci Technol; 2020 Sep; 14(5):972-973. PubMed ID: 32059616
    [No Abstract]   [Full Text] [Related]  

  • 39. New Insulins and New Aspects in Insulin Delivery.
    Woo VC
    Can J Diabetes; 2015 Aug; 39(4):335-43. PubMed ID: 26233724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoamine Oxidase Inhibition in a Patient With Type 1 Diabetes and Depression.
    Emory H; Mizrahi N
    J Diabetes Sci Technol; 2016 Sep; 10(5):1203-4. PubMed ID: 26961977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.